OSR Health OSRH
NASDAQ OSRH
$0.20 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

OSR Health (OSRH) Net Margin (2024 - 2026)

OSR Health's (OSRH) quarterly Net Margin came in at 268.92% in Q2 2026, down 29811.0% year-over-year from N/an in Q2 2025, and up 55.59% quarter-over-quarter from 605.6% in Q1 2026.

Analysis

OSR Health (OSRH) Net Margin (2024 - 2026) Analysis & Trends

OSR Health has disclosed Net Margin across 3 years of filings, most recently posting 268.92% for Q2 2026.

  • In Q2 2026, Net Margin fell 29811.0% year-over-year to 268.92%; the TTM figure through Jun 2026 stood at 593.22% (down 15973.0% YoY), while the FY2025 annual figure was 619.82%, down 32725.0% from the prior year.
  • Net Margin came in at 268.92% for Q2 2026 at OSR Health, up from 605.6% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 29.19% in Q2 2025 to a low of 1496.55% in Q1 2025.
  • Average Net Margin over 3 years is 512.67%, with a median of 353.7% recorded in 2024.
  • Year-over-year, Net Margin plunged 112792 bps in 2025 and surged 89095 bps in 2026.
  • Over 3 years, Net Margin stood at 146.36% in 2024, then plunged by 764 bps to 1264.96% in 2025, then surged by 79 bps to 268.92% in 2026.
  • Per Business Quant data, the three most recent Net Margin figures were 268.92% in Q2 2026, 605.6% in Q1 2026, and 1264.96% in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 23.62%
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -134.51%
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 32.99%
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 30.23%
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 31.16%
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -539.31%
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 12.74%
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 3.56%
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -20,152.98%
10 OSR Health 6.59 Mn 4.94 Mn 86,605.00 -268.92%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -268.92%
Mar 31, 2026 -605.60%
Dec 31, 2025 -1,264.96%
Sep 30, 2025 -338.77%
Jun 30, 2025 29.19%
Mar 31, 2025 -1,496.55%
Dec 31, 2024 -146.36%
Sep 30, 2024 -407.84%
Jun 30, 2024 -258.27%
Mar 31, 2024 -368.63%